Viewing Study NCT01275794


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2025-12-26 @ 4:20 AM
Study NCT ID: NCT01275794
Status: COMPLETED
Last Update Posted: 2012-06-04
First Post: 2011-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module